| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_42e94091a4fc81b8d0237117707cc7ee |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07B2200-09 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-497
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D413-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D413-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4523
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-454
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D413-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-5355
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-24 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-24
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-454
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-5355
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D413-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D413-04 |
| filingDate |
2016-10-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3c80aaa90186e57f3e3b5a88912fb710
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6642e57e4549833ef85aab38480741c5
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fcf8e437843e0467fb8f282154c94497
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d17516e0640cabaf4025bfe81a042c8a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_084d523d3265e0dc82b8ac8515d78302
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e85835b18af0d8ab8700f3631b706022 |
| publicationDate |
2018-06-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
KR-20180064507-A |
| titleOfInvention |
Selective NR2B antagonist |
| abstract |
The present disclosure provides compounds of formula (I) and pharmaceutically acceptable salts thereof. The compounds of formula (I) are ligands of the NR2B N-methyl-D-aspartate (NMDA) receptor and are therefore useful in the treatment of various central nervous system disorders. |
| priorityDate |
2015-10-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |